Understanding how Epac signaling affects kidney function and blood pressure
Significance of Epac signaling in renal Na+handling and hypertension
This study is looking at how a specific signaling process in the kidneys affects salt and water balance, with the goal of finding new ways to help people with high blood pressure by targeting different systems that manage sodium.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Texas Hlth Sci Ctr Houston NIH-funded |
| Lab location | 1 site (Houston, United States) |
| Project ID | NIH-10948044 on NIH RePORTER |
What this research studies
This research investigates the role of Epac signaling in the kidneys, which is crucial for managing salt and water balance in the body. By examining how Epac isoforms influence sodium handling in different parts of the kidney, the study aims to develop new treatments for hypertension that target multiple sodium transport systems simultaneously. The researchers will use advanced techniques, including genetic modifications in animal models, to explore the effects of inhibiting Epac on blood pressure regulation. This approach could lead to more effective therapies for patients with high blood pressure.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals suffering from hypertension or those at risk of developing high blood pressure.
Not a fit: Patients with normal blood pressure or those whose hypertension is not related to renal sodium handling may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new, more effective treatments for hypertension that improve blood pressure control.
How similar studies have performed: Previous research has shown promising results in targeting sodium transport mechanisms for hypertension treatment, suggesting that this approach could be effective.
Where this research is happening
Houston, United States
- University of Texas Hlth Sci Ctr Houston — Houston, United States (Active)
Researchers
- Principal investigator: Pochynyuk, Oleh — University of Texas Hlth Sci Ctr Houston
- Study coordinator: Pochynyuk, Oleh
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.